Preoperative CA‐125 level as a predictor of non optimal cytoreduction of advanced epithelial ovarian cancer
- 1 June 2001
- journal article
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 80 (6), 583-585
- https://doi.org/10.1034/j.1600-0412.2001.080006583.x
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Preoperative Prediction of Optimal Resectability in Advanced Ovarian Cancer Using CA-125Gynecologic Oncology, 2000
- The Ability of Preoperative Serum CA-125 to Predict Optimal Primary Tumor Cytoreduction in Stage III Epithelial Ovarian CarcinomaGynecologic Oncology, 2000
- Neoadjuvant Chemotherapy for Advanced Ovarian Cancer: Long-Term SurvivalGynecologic Oncology, 1999
- Neoadjuvant Chemotherapy or Primary Debulking Surgery in Advanced Ovarian Carcinoma: A Retrospective Analysis of 285 PatientsGynecologic Oncology, 1998
- Cytoreduction for advanced ovarian cancer in perspectiveInternational Journal of Gynecologic Cancer, 1996
- The Effect of Debulking Surgery after Induction Chemotherapy on the Prognosis in Advanced Epithelial Ovarian CancerNew England Journal of Medicine, 1995
- The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinomaAmerican Journal of Obstetrics and Gynecology, 1994
- The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume Stage III epithelial ovarian cancer: A gynecologic oncology group studyGynecologic Oncology, 1992